Investigating the Anti-Inflammatory, Analgesic, and Chondroprotective Effects of Gynostemma pentaphyllum (Thunb.) Makino in Osteoarthritis: An In Vitro and In Vivo Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179594 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hee-Geun Jo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Herbal Pharmacology, College of Korean Medicine, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam-si 13120, Republic of Kor…. Hauptthemen laut MEDLINE: Gynostemma, Osteoarthritis, Anti-Inflammatory Agents, Plant Extracts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, Korea Health Industry Development Institute (KHIDI), Ministry of Health and Welfare, Republic of Korea.
Abstract (Originalsprache)
Osteoarthritis (OA) is an age-related disease characterized by inflammation, pain, articular cartilage damage, synovitis, and irreversible disability. Gynostemma pentaphyllum (Thunb.) Makino (GP), a herbal medicine traditionally used in East Asia for its anti-inflammatory properties, was investigated for its potential to modulate OA pathology and symptoms. This study evaluated GP’s efficacy in inhibiting pain, functional decline, and cartilage destruction in monosodium iodoacetate-induced OA and acetic acid-induced writhing models. Additionally, the effects of GP on OA-related inflammatory targets were assessed via mRNA and protein expression in rat knee cartilage and lipopolysaccharide-induced RAW 264.7 cells. The GP group demonstrated significant pain relief, functional improvement, and cartilage protection. Notably, GP inhibited key inflammatory mediators, including interleukin (IL)-1β, IL-6, matrix metalloproteinases (MMP)-3 and MMP-13, cyclooxygenase-2, and prostaglandin E receptor 2, surpassing the effects of active controls. These findings suggest that GP is a promising candidate for disease-modifying OA drugs and warrants further comprehensive studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Herbal Pharmacology, College of Korean Medicine, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam-si 13120, Republic of Korea.
- Naturalis Inc., 6 Daewangpangyo-ro, Bundang-gu, Seongnam-si 13549, Republic of Korea.
- RexSoft Inc., 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.
- Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam-si 13120, Republic of Korea.
ORCID-Profile: Hee-Geun Jo, Chae Yun Baek, Yeseul Hwang, Ho Sueb Song, Donghun Lee
Förderung
- Ministry of Health and Welfare
- Korea Health Industry Development Institute (KHIDI)
- Ministry of Health and Welfare, Republic of Korea
Zitieren
APA
Jo, H. G., Baek, C. Y., Hwang, Y., Baek, E., Park, C., Song, H. S., & Lee, D. (2024). Investigating the Anti-Inflammatory, Analgesic, and Chondroprotective Effects of Gynostemma pentaphyllum (Thunb.) Makino in Osteoarthritis: An In Vitro and In Vivo Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179594
Vancouver
Jo HG, Baek CY, Hwang Y, Baek E, Park C, Song HS, et al. Investigating the Anti-Inflammatory, Analgesic, and Chondroprotective Effects of Gynostemma pentaphyllum (Thunb.) Makino in Osteoarthritis: An In Vitro and In Vivo Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179594
BibTeX
@article{Jo2024,
author = {Jo, Hee-Geun and Baek, Chae Yun and Hwang, Yeseul and Baek, Eunhye and Park, Chanyoon and Song, Ho Sueb and Lee, Donghun},
title = {Investigating the Anti-Inflammatory, Analgesic, and Chondroprotective Effects of Gynostemma pentaphyllum (Thunb.) Makino in Osteoarthritis: An In Vitro and In Vivo Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179594}
}
EUVIMED